Clayton Kershaw was back on the field with the Los Angeles Dodgers on Tuesday in another sign the three-time Cy Young Award winner is returning for ...

Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...

The Fridley City Council, at the Jan. 27 meeting, unanimously approved a preliminary report for traffic calming improvements at East Danube Road.

Key Insights Given the large stake in the stock by institutions, Cardinal Health's stock price might be vulnerable ...

Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

The rapper has mastered the delicate balance between commercial success and politically charged music. How far will he push ...

Cardinal Health (NYSE:CAH – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from ...

Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...